More Losses

Layoffs are hitting Sanofi-Aventis and possibly Astra-Zeneca and Eli Lilly, says Derek Lowe at In the Pipeline. He says that Astra-Zeneca's cuts may be "follow-through from their earlier nonspecific announcements - it looks as if they're finally going to start getting down to some details" and that at Lilly, some chemistry positions may be lost.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.